Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Influence of implant strategy on the transition from temporary left ventricular assist device to durable mechanical circulatory support

AL. Meyer, D. Lewin, M. Billion, S. Hofmann, I. Netuka, J. Belohlavek, K. Jawad, D. Saeed, B. Schmack, SV. Rojas, J. Gummert, A. Bernhardt, G. Färber, J. Kooij, B. Meyns, A. Loforte, M. Pieri, AM. Scandroglio, P. Akhyari, MK. Szymanski, CH....

. 2024 ; 66 (4) : . [pub] 20241001

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25004008

OBJECTIVES: Bridging from a temporary microaxial left ventricular assist device (tLVAD) to a durable left ventricular assist device (dLVAD) is playing an increasing role in the treatment of terminally ill patients with heart failure. Scant data exist about the best implant strategy. The goal of this study was to analyse differences in the dLVAD implant technique and effects on patient outcomes. METHODS: Data from 341 patients (19 European centres) who underwent a bridge-to-bridge implant from tLVAD to dLVAD between January 2017 and October 2022 were retrospectively analysed. The outcomes of the different implant techniques with the patient on cardiopulmonary bypass, extracorporeal life support or tLVAD were compared. RESULTS: A durable LVAD implant was performed employing cardiopulmonary bypass in 70% of cases (n = 238, group 1), extracorporeal life support in 11% (n = 38, group 2) and tLVAD in 19% (n = 65, group 3). Baseline characteristics showed no significant differences in age (P = 0.140), body mass index (P = 0.388), creatinine level (P = 0.659), the Model for End-Stage Liver Disease (MELD) score (P = 0.190) and rate of dialysis (P = 0.110). Group 3 had significantly fewer patients with preoperatively invasive ventilation and cardiopulmonary resuscitation before the tLVAD was implanted (P = 0.009 and P < 0.001 respectively). Concomitant procedures were performed more often in groups 1 and 2 compared to group 3 (24%, 37% and 5%, respectively, P < 0.001). The 30-day mortality data showed significantly better survival after an inverse probability of treatment weighting in group 3, but the 1-year mortality showed no significant differences among the groups (P = 0.012 and 0.581, respectively). Postoperative complications like the rate of right ventricular assist device (RVAD) implants or re-thoracotomy due to bleeding, postoperative respiratory failure and renal replacement therapy showed no significant differences among the groups. Freedom from the first adverse event like stroke, driveline infection or pump thrombosis during follow-up was not significantly different among the groups. Postoperative blood transfusions within 24 h were significantly higher in groups 1 and 2 compared to surgery on tLVAD support (P < 0.001 and P = 0.003, respectively). CONCLUSIONS: In our analysis, the transition from tLVAD to dLVAD without further circulatory support did not show a difference in postoperative long-term survival, but a better 30-day survival was reported. The implant using only tLVAD showed a reduction in postoperative transfusion rates, without increasing the risk of postoperative stroke or pump thrombosis. In this small cohort study, our data support the hypothesis that a dLVAD implant on a tLVAD is a safe and feasible technique in selected patients.

2nd Department of Internal Medicine Cardiovascular Medicine General Teaching Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Anesthesia and Intensive Care IRCCS San Raffaele Scientific Institute Milan Italy

Department of Cardiac and Vascular Surgery University of Mainz Mainz Germany

Department of Cardiac Surgery Heart Center Bonn University Hospital Bonn Bonn Germany

Department of Cardiac Surgery Heidelberg University Hospital Heidelberg Germany

Department of Cardiac Surgery IRCCS Azienda Ospedaliero Universitaria di Bologna St Orsola University Hospital Bologna Italy

Department of Cardiac Surgery Leipzig Heart Center Leipzig Germany

Department of Cardiac Surgery Saarland University Medical Center and Saarland University Homburg Saar Homburg Germany

Department of Cardiac Surgery Schüchtermann Clinic Bad Rothenfelde Germany

Department of Cardiac Surgery University Hospital Leuven Leuven Belgium

Department of Cardiology Rigshospitalet Copenhagen Denmark

Department of Cardiology University Medical Center Utrecht Utrecht Netherlands

Department of Cardiothoracic and Vascular Surgery Deutsches Herzzentrum der Charité Berlin Germany

Department of Cardiothoracic Surgery Rigshospitalet Copenhagen Denmark

Department of Cardiothoracic Surgery University Hospital Cologne Cologne Germany

Department of Cardiothoracic Surgery University Hospital RTWH Aachen Aachen Germany

Department of Cardiothoracic Transplantation and Vascular Surgery Hanover Medical School Hanover Germany

Department of Cardiovascular Surgery Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Cardiovascular Surgery University Heart Center Hamburg Hamburg Germany

Department of Cardiovascular Surgery University Hospital Schleswig Holstein Kiel Germany

Department of Surgical Sciences University of Turin Turin Italy

Department of Thoracic and Cardiovascular Surgery Heart and Diabetes Center of North Rhine Westphalia Bad Oeynhausen Germany

Division of Cardiac Surgery Department of Surgery Medical University of Vienna Vienna Austria

DZHK Partner site Berlin Berlin Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25004008
003      
CZ-PrNML
005      
20250206105035.0
007      
ta
008      
250121s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ejcts/ezae333 $2 doi
035    __
$a (PubMed)39259187
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Meyer, A L $u Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany $1 https://orcid.org/0000000248338014
245    10
$a Influence of implant strategy on the transition from temporary left ventricular assist device to durable mechanical circulatory support / $c AL. Meyer, D. Lewin, M. Billion, S. Hofmann, I. Netuka, J. Belohlavek, K. Jawad, D. Saeed, B. Schmack, SV. Rojas, J. Gummert, A. Bernhardt, G. Färber, J. Kooij, B. Meyns, A. Loforte, M. Pieri, AM. Scandroglio, P. Akhyari, MK. Szymanski, CH. Moller, F. Gustafsson, M. Medina, M. Oezkur, D. Zimpfer, I. Krasivskyi, I. Djordjevic, A. Haneya, J. Stein, P. Lanmueller, EV. Potapov, J. Kremer
520    9_
$a OBJECTIVES: Bridging from a temporary microaxial left ventricular assist device (tLVAD) to a durable left ventricular assist device (dLVAD) is playing an increasing role in the treatment of terminally ill patients with heart failure. Scant data exist about the best implant strategy. The goal of this study was to analyse differences in the dLVAD implant technique and effects on patient outcomes. METHODS: Data from 341 patients (19 European centres) who underwent a bridge-to-bridge implant from tLVAD to dLVAD between January 2017 and October 2022 were retrospectively analysed. The outcomes of the different implant techniques with the patient on cardiopulmonary bypass, extracorporeal life support or tLVAD were compared. RESULTS: A durable LVAD implant was performed employing cardiopulmonary bypass in 70% of cases (n = 238, group 1), extracorporeal life support in 11% (n = 38, group 2) and tLVAD in 19% (n = 65, group 3). Baseline characteristics showed no significant differences in age (P = 0.140), body mass index (P = 0.388), creatinine level (P = 0.659), the Model for End-Stage Liver Disease (MELD) score (P = 0.190) and rate of dialysis (P = 0.110). Group 3 had significantly fewer patients with preoperatively invasive ventilation and cardiopulmonary resuscitation before the tLVAD was implanted (P = 0.009 and P < 0.001 respectively). Concomitant procedures were performed more often in groups 1 and 2 compared to group 3 (24%, 37% and 5%, respectively, P < 0.001). The 30-day mortality data showed significantly better survival after an inverse probability of treatment weighting in group 3, but the 1-year mortality showed no significant differences among the groups (P = 0.012 and 0.581, respectively). Postoperative complications like the rate of right ventricular assist device (RVAD) implants or re-thoracotomy due to bleeding, postoperative respiratory failure and renal replacement therapy showed no significant differences among the groups. Freedom from the first adverse event like stroke, driveline infection or pump thrombosis during follow-up was not significantly different among the groups. Postoperative blood transfusions within 24 h were significantly higher in groups 1 and 2 compared to surgery on tLVAD support (P < 0.001 and P = 0.003, respectively). CONCLUSIONS: In our analysis, the transition from tLVAD to dLVAD without further circulatory support did not show a difference in postoperative long-term survival, but a better 30-day survival was reported. The implant using only tLVAD showed a reduction in postoperative transfusion rates, without increasing the risk of postoperative stroke or pump thrombosis. In this small cohort study, our data support the hypothesis that a dLVAD implant on a tLVAD is a safe and feasible technique in selected patients.
650    _2
$a lidé $7 D006801
650    12
$a podpůrné srdeční systémy $7 D006353
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a lidé středního věku $7 D008875
650    12
$a srdeční selhání $x chirurgie $x terapie $7 D006333
650    _2
$a senioři $7 D000368
650    _2
$a výsledek terapie $7 D016896
650    _2
$a dospělí $7 D000328
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Lewin, D $u Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany
700    1_
$a Billion, M $u Department of Cardiac Surgery, Schüchtermann Clinic, Bad Rothenfelde, Germany
700    1_
$a Hofmann, S $u Department of Cardiac Surgery, Schüchtermann Clinic, Bad Rothenfelde, Germany
700    1_
$a Netuka, I $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Belohlavek, J $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Second Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000194559224 $7 xx0077681
700    1_
$a Jawad, K $u Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany
700    1_
$a Saeed, D $u Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany $1 https://orcid.org/0000000174499455 $7 xx0321697
700    1_
$a Schmack, B $u Department of Cardiothoracic, Transplantation and Vascular Surgery, Hanover Medical School, Hanover, Germany
700    1_
$a Rojas, S V $u Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center of North Rhine-Westphalia, Bad Oeynhausen, Germany $1 https://orcid.org/0000000295051358
700    1_
$a Gummert, J $u Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center of North Rhine-Westphalia, Bad Oeynhausen, Germany $1 https://orcid.org/0000000269569110
700    1_
$a Bernhardt, A $u Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
700    1_
$a Färber, G $u Department of Cardiac Surgery, Saarland University Medical Center and Saarland University Homburg/Saar, Homburg, Germany
700    1_
$a Kooij, J $u Department of Cardiac Surgery, University Hospital Leuven, Leuven, Belgium
700    1_
$a Meyns, B $u Department of Cardiac Surgery, University Hospital Leuven, Leuven, Belgium $1 https://orcid.org/0000000281104009
700    1_
$a Loforte, A $u Department of Cardiac Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, St Orsola University Hospital, Bologna, Italy $u Department of Surgical Sciences, University of Turin, Turin, Italy $1 https://orcid.org/0000000236890477
700    1_
$a Pieri, M $u Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
700    1_
$a Scandroglio, A M $u Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy
700    1_
$a Akhyari, P $u Department of Cardiothoracic Surgery, University Hospital RTWH Aachen, Aachen, Germany
700    1_
$a Szymanski, M K $u Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands
700    1_
$a Moller, C H $u Department of Cardiothoracic Surgery Rigshospitalet, Copenhagen, Denmark
700    1_
$a Gustafsson, F $u Department of Cardiology, Rigshospitalet, Copenhagen, Denmark $1 https://orcid.org/000000032144341X
700    1_
$a Medina, M $u Department of Cardiac and Vascular Surgery, University of Mainz, Mainz, Germany
700    1_
$a Oezkur, M $u Department of Cardiac and Vascular Surgery, University of Mainz, Mainz, Germany $1 https://orcid.org/000000021284066X
700    1_
$a Zimpfer, D $u Division of Cardiac Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000221854895
700    1_
$a Krasivskyi, I $u Department of Cardiac Surgery, Heart Center Bonn, University Hospital Bonn, Bonn, Germany
700    1_
$a Djordjevic, I $u Department of Cardiothoracic Surgery, University Hospital Cologne, Cologne, Germany
700    1_
$a Haneya, A $u Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany
700    1_
$a Stein, J $u Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany
700    1_
$a Lanmueller, P $u Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany $u DZHK (German Centre for Cardiovascular Research), Partner site Berlin, Berlin, Germany
700    1_
$a Potapov, E V $u Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany $u DZHK (German Centre for Cardiovascular Research), Partner site Berlin, Berlin, Germany
700    1_
$a Kremer, J $u Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany
773    0_
$w MED00001607 $t European journal of cardio-thoracic surgery $x 1873-734X $g Roč. 66, č. 4 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39259187 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206105030 $b ABA008
999    __
$a ok $b bmc $g 2263634 $s 1240015
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 66 $c 4 $e 20241001 $i 1873-734X $m European journal of cardio-thoracic surgery $n Eur J Cardiothorac Surg $x MED00001607
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...